Naturally Splendid Plantein Adds Greenbridge Distributor Network |

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSX-V:NSP)(OTC:NSPDF) is pleased to announce the Company has successfully negotiated a purchasing program for its PlanteinTM plant-based entrees with Greenbridge Foodservice, a group of Independent Distributors across Canada

Greenbridge Foodservice will market the complete PlanteinTM line including Burgers; Nuggets; Crumbed Tenders; Sweet Chili Tenders; Schnitzel; Garlic Kiev; and Phishy Fillet throughout their extensive network and has already received their first purchase order.

Greenbridge Foodservice is a national sales and marketing organization that supports Canadian privately owned and operated foodservice distributors across Canada. Collectively, the group is comprised of seven (7) distributor members from coast to coast, with fifteen (15) distribution centres and an estimated 250 sales professionals.

CEO Mr. Craig Goodwin states, "We are pleased to have our PlanteinTM products available through the Greenbridge Foodservice. This collective group of independent distributors compliments the distribution network we have initiated and increases the availability of our healthy plant-based foods across Canada. Having PlanteinTM available in Greenbridge's distribution centres will allow us to serve our current customers better and reach new ones. We look forward to growing our PlanteinTM business with Greenbridge."

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a plant-based food manufacturing and technology company that produces and distributes nutritious and delicious plant-based commodity products.

Founded in 2010, the Company operates a certified food manufacturing facility located just outside Vancouver, BC in Canada, focusing on producing an extensive range of plant-based entrees.

Naturally Splendid has an exclusive 10-year manufacturing and distribution agreement for Canada with a division of Australia's largest plant-based food manufacturer, Flexitarian Foods Pty. Ltd.

The Company has established healthy, functional foods under brands such as Natera Sport, Natera Hemp Foods, CHII™, Elevate Me™ and Woods Wild Bar™. The Company launched Plantein Plant-Based Foods, a line of delicious plant-based meat alternatives for the rapidly growing plant-based market segment.

Naturally Splendid has reached an agreement with Biologic to terminate the agreement with Plasm Pharmaceutical and is negotiating a compensation package for work done to date pursuing a potential treatment for Covid with the target drug Cavaltinib.

NSE has also developed proprietary technologies for the extraction of healthy omega 3 and 6 oils, as well as a protein concentrate from hemp.

On Behalf of the Board of Directors

Mr. J. Craig Goodwin President, Director

Naturally Splendid Enterprises Ltd. (NSP - TSX Venture; NSPDF - OTCQB; 50N Frankfurt) #108-19100 Airport Way Pitt Meadows, BC, V3Y 0E2 Office: (604) 570-0902 E-mail: info@naturallysplendid.com Website: www.naturallysplendid.com

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control including, Naturally Splendid's ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; customers will complete on sales contracts; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE: Naturally Splendid Enterprises Ltd.

News Provided by ACCESSWIRE via QuoteMedia

The plant-based meat market is expected to grow at an impressive CAGR of 25.14 percent as consumers seek more plant-based options. The segment has the potential to grow by US$7.21 billion from 2015 to 2021. In 2019 alone, the plant-based meat market was valued at a significant US$3.77 billion. The high growth rate of this segment of the plant-based market presents an exciting opportunity for investors seeking to grow their capital.

A key geographic market in the plant-based category is North America, and Canada is a global leader in plant protein. The Government of Canada recently invested C$153 million into the Protein Industries SuperCluster, which seeks to increase the value of key Canadian crops such as canola, wheat and pulses. A significant opportunity for these crops revolves around the growing plant-based meat alternatives markets in North America, with further export opportunities in Asia and Europe. The Canadian government expects the investment to generate more than C$4.5 billion in GDP over the next 10 years.

Naturally Splendid Enterprises (TSXV:NSP, OTCQB:NSPDF, FSE:50N) is a Canadian-based company focused on manufacturing delicious plant-based products. Their feature plant-based line is marketed under the PlanteinTM trademark. This line is manufactured under a 10-year exclusive manufacturing and distribution agreement with Flexitarian Foods Pty. Ltd., a division of Australia’s largest plant-based manufacturer.

As a result of this agreement, Naturally Splendid offers the most extensive plant-based meat alternative choices than any other plant protein company in North America, including Beyond Meat (NASDAQ: BYND), Gardein (owned by Conagra NASDAQ: CAG) and Impossible Meat.

Over the years, Naturally Splendid has developed a number of retail brands covering various consumer channels that have been sold in thousands of retail locations across Canada and online. The Company’s feature plant-based line boasts a number of appetizers and entrees prepared for those looking to add more plant-based nutrition into their diets, whether they be vegans, vegetarians or the rapidly growing ‘flexitarian consumer.’

ProSnack Natural Foods, a 100% owned division of Naturally Splendid, manufactures plant-based appetizers and entrees in their 17,000 square foot Safe Quality Food (SQF) Certified food manufacturing facility located in Pitt Meadows, British Columbia in, Canada. The facility is capable of manufacturing a wide range of plant-based appetizers and entrees. While upgrading the Prosnack facility, the SQF Certification is temporarily on hold at the request of Company. SQF pre-certification inspection is expected in October 2022 with full certification expected Q2 2023. Previously the Company scored an 89/100 during their SQF certification process, indicating a high aptitude for manufacturing processes.

The facility is currently undergoing renovations to replicate the established, successful manufacturing processes that have made Plantein among Australia’s most popular plant-based entrees. Once completed in the latter part of 2022, the facility will have the capacity to produce 30 tons of plant-based products daily, or in dollar values, will have a manufacturing capacity of $45,000,000 CDN annually.

In addition to Naturally Splendid’s house brand, ‘Plantein,’ ProSnack will manufacture under Private Label agreements and manufacture for strategically selected companies, producing their proprietor formulations for plant-based products.

Flexitarian Foods has developed industry-disrupting IP in both product R&D as well as manufacturing. Rather than develop a ‘recipe’ for a single product, as most every other plant-based manufacturer does, Flexitarian Foods has perfected a system based on their IP for rapid product development. Flexitarian Food’s IP extends to manufacturing, and its success lies in using standardized equipment rather than custom manufactured equipment to process their plant-based foods.

The IP regarding product formulation creates the landscape to develop new plant-based SKUs in industry-leading time frames…typically 6-10 weeks for initial concept samples to be developed.

IP related to manufacturing provides a competitive pricing advantage due to the efficiency of the Company’s manufacturing processes. Flexitarian Food’s methodology based on their IP allows for rapid expansion to manufacturing capacity as capacity can be increased simply by adding additional equipment. This strategy lends itself to the opportunity to build multiple manufacturing facilities close to input sources and consumer bases, creating competitive advantages.

Initially, Naturally Splendid marketed its plant-based products under its Natera brand. The Company has since negotiated a 10-year licensing agreement to use the Plantein name in Canada. The licensing agreement has a 10-year extension, making this a 20-year agreement.

In August 2021, the company announced an exciting milestone in which NATERA’s plant-based chicken tenders and plant-based chicken nuggets will soon be available at 71 Denny’s Corporation (NASDAQ:DENN) restaurant locations across Canada. These items are currently being served in all Canadian Denny’s locations.

The Company has established relationships with Canada’s two largest food distributors, who in combination hold an estimated 85% market share.

Gordon Food Service (GFS) – Services Denny’s Canada account as well as others

Naturally Splendid’s initial foray into plant-based nutrition began over a decade ago and focused on hemp and the incredible nutritional profile the plant provided. The Company’s journey has included significant technological advances in hemp protein and the omegas contained in hemp, resulting in unique ingredients that may be incorporated into plant-based product formulations. Naturally Splendid is the owner of Chii Pure Hemp, an online store selling hemp seed and protein and manufactures nutritional bars and bites in their certified food manufacturing facility. This facility is now being retrofitted to manufacture a diverse range of plant-based appetizers and entrees. The Company’s previous technological advances in the area of micro-encapsulation of omegas and concentrating of plant proteins, has provided an opportunity to use these value-added ingredients in their own plant-based products. Additionally, these value-added ingredients have the potential to be marketed to other plant-based manufacturers creating new revenue stream. The opportunity within the plant-based market space has created new opportunities for these Company owned technologies and ingredients.

In addition to the Company’s plant-based appetizer and entree business, Naturally Splendid’s other plant-based brands include CHII, ElevateMe, NATERA Sport, and Pawsitive FX. CHII is one of Canada’s oldest hemp companies, established in 2019. The brand offers hemp seeds, oils, and proteins sold primarily online. Elevate Me, and Woods Wild Bars are the company’s bars offerings. These products are currently going through re-formulation to offer 100% plant-based nutrition. Pawsitive FX is the company’s foray into topical pet products, which feature 100% plant-based formulations.

ProSnack Natural Foods operates a 17,000 square foot Safe Quality Food (SQF) Certified Food Manufacturing facility in Pitt Meadows, British Columbia, Canada.

ProSnack Natural Foods facility is undergoing retrofitting and will manufacture the Plantein line of plant-based products upon commissioning. Upon retrofit completion, the facility will be capable of producing 30 tons of plant-based products per day, resulting in a manufacturing capacity in dollars of an estimated $40M CDN annually.

Additionally, and as importantly, Prosnack Natural Foods offers contract manufacturing for various clients, including private label programs.

Prior to retrofitting to manufacture plant-based entrees, Prosnack manufactured nutritional bars and bites for themselves under multiple ‘house brands’ and several well-known brands.

Naturally Splendid has secured the rights to use the Plantein name in Canada exclusively for an initial 10-year term with a 10-year renewal option.

Plantein originated in Australia and is manufactured by a division of the largest plant-based manufacturer in Australia.

The PlanteinTM line of plant-based foods includes alternatives for beef, chicken, pork, fish and seafood. The Company has over 40 commercially ready plant-based entrees and has launched eight (8) SKUs initially in foodservice and retail in Canada.

The eight (8) products available today are 100% vegan and include a plant-based Burger, Crispy Burger, Crumbed Tenders, Sweet Chili Tenders, Nuggets, Schnitzel, Garlic Kiev and Phishy Fillet.

Naturally Splendid has developed and owns several brands covering multiple categories, including CHII Pure Hemp, Elevate Me, Woods Wild Bar, NATERA Sport and Pawsitive FX focusing on plant-based ingredients.

CHII is one of Canada’s pioneering hemp companies, established in 1998. The brand offers hemp hearts, hemp oil and hemp seed protein through an online e-commerce platform. Chii hemp foods include hemp seed hearts, hemp protein powder and hemp seed oil.

The Company has developed, manufactured and distributed several nutritional bars and bites, including Elevate Me, Woods Wild Bar and KEY-TO-LIFE.

NATERA Sport also recently launched Procurc 30, an advanced curcumin-based supplement that Health Canada approved for phase two clinical trial as a potential treatment for Covid-19.

Pawsitive FX consists of three (3) all-natural balms for snout and paw health; Happy Paws, Strong Paws, Happy Snouts.Pawsitive FX as well as offers raw hemp oil for canine nutrition!

J. Craig Goodwin is a co-founder of Naturally Splendid. As CEO, Goodwin has been instrumental in the transition from a private company to a public company raising over CA$20,000,000 in the process. In addition to his role as CEO, Goodwin’s responsibilities included international business development where he oversaw the development of a South Korean project generating over C$7,000,000 in 2016.

Currently, Goodwin is developing business in South Korea, Japan, China, Germany and Australia to name a few. Previous to his appointment as CEO of Naturally Splendid, Goodwin accumulated over 30 years of sales and marketing experience including senior account executive for one of the largest outdoor advertising companies in the world, The Jim Pattison Sign Group. While with The Jim Pattison Sign Group, Craig was one of the most successful sales executives in Western Canada and received numerous awards for outstanding sales achievements.

In addition to sales and marketing, Goodwin has consulted for numerous public companies providing services including investor relations, raising venture capital and business development.

Bryan Carson’s vision of a company distributing healthy food choices is a driving force behind Naturally Splendid® and the foundations from which this company originated. For the past four years, Carson has overseen the operations of Naturally Splendid® including establishing supply channels, packaging and product development. Carson’s insight and vision have proved invaluable as part of the management team.

Carson created, operated and sold a successful retail store in Vancouver, B.C. His hands-on retail expertise from the conceptual planning stages through construction and launch is of great value in developing our relationship with major food distribution channels.

George Ragogna has over 30 years of experience in the Canadian financial services industry. Ragogna also has over 20 years of experience in a progressive leadership role specializing in strategic planning, corporate sales, workforce optimization and regulatory compliance. Ragogna successfully manages and supports a call center of over 550 employees, ensuring new and existing staff are trained and knowledgeable in the financial services industry and compliance processes.

Ragogna brings unique business acumen and strong technical skills that will strengthen the board at Naturally Splendid.

Larry Gilmour's professional career began in sales and marketing with internationally recognized brands such as Libby's (Libby, McNeil and Libby), Playtex Corp. and Black and Decker. Gilmour has also owned and operated chain grocery outlets including owner and operator of a Super Valu grocery store in Vancouver, B.C., for over five years. He has a successful track record of growing businesses with existing consumer bases.

Gilmour joined Independent Pharmacist Inc. where he leveraged his sales, marketing and management skills to drive membership up significantly –– increasing sales tenfold from $2 million to $22 million over four years. When the business was sold, Gilmour built another business called Vancouver Wholesale Drugs. Gilmour was a partner and general manager of Vancouver Wholesale Drugs and oversaw a sales increase from $5 million to $70 million in just six years. Gilmour then returned to the grocery world purchasing an IGA grocery store in Vancouver, B.C., that he operated for over eight years. More recently, Gilmour has been advising business owners of small- to medium-sized businesses in infrastructure, financing, sales and marketing.

Kris Tarr's professional career has spanned almost three decades as an information technology and internet marketing consultant. Tarr has held several senior marketing management and IT executive positions, applying his decades of experience in technology, management and leadership to deliver business results for organizations in the high-tech, pharmaceutical, tourism, entertainment, online gaming and real estate sectors.

Tarr has worked for globally recognized organizations such as Coca-Cola, Disney and Nickelodeon. As a consultant, he has guided over a hundred small and medium-sized businesses, developing and implementing online and e-commerce strategies.

In Vancouver, Canada, Tarr focused on internet marketing with an emphasis on search engine optimization and social media automation for the online gaming industry. Tarr held a position as senior SEO strategist for Bodog which is a major online gaming brand. Tarr has also held the positions of ITSM (IT service management) head, chief technology officer and IT solutions provider at Oriental Game which is Asia's leading online gaming solutions provider.

Tarr has started numerous lucrative business ventures and has built and operated many successful search engines including a property management franchise. He co-founded Waveless Websystems Inc., where he developed e-commerce solutions for the home building industry, which led him to Southeast Asia to expand the company's software development team.

VANCOUVER, BC / ACCESSWIRE/ September 6, 2022 / Naturally Splendid Enterprises Ltd.("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSXV:NSP)(OTC Pink:NSPDF) is pleased to announce that Vegan Supply will carry a selection of PlanteinTM products for its retail and foodservice customers.

Vegan Supply, a Vancouver based company with both retail and foodservice distribution, began business in 2015 as the world's largest e-commerce marketplace exclusively providing their retail customers and foodservice clients with high-quality vegan products. Vegan Supply is listing five (5) PlanteinTM plant-based entrees: Nuggets, Schnitzel, Crumbed Tenders, Sweet Chili Tenders, and Crispy Burgers. The PlanteinTM line of products will be available through Vegan Supply's retail store in Vancouver, BC, their e-commerce platform, and marketed to their foodservice distribution network.

"To partner with a forward-thinking company like Vegan Supply and supply its customers with our products means a lot," said Executive Vice President Bryan Carson. "Although our products are intended for all types of consumers, being accepted by the vegan community does speak to the quality of our products. The vegan market continues to grow and it is our mission to provide all our customers with the products they want and need. We look forward to working with Vegan Supply and providing their clients with great tasting PlanteinTM products". About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a plant-based food manufacturing and technology company that produces and distributes nutritious and delicious plant-based commodity products. Founded in 2010, the Company operates a certified food manufacturing facility located just outside Vancouver, BC in Canada, focusing on producing an extensive range of plant-based entrees. Naturally Splendid has an exclusive 10-year manufacturing and distribution agreement for Canada with a division of Australia's largest plant-based food manufacturer, Flexitarian Foods Pty. Ltd.

In addition to producing the Company's own branded products, Naturally Splendid provides contract manufacturing services and private labelling for a variety of nutritional plant-based food products destined for multiple distribution channels. The Company has established healthy, functional foods under brands such as Natera Sport, Natera Hemp Foods, CHII™, Elevate Me™ and Woods Wild Bar™. The Company launched Plantein Plant-Based Foods, a line of delicious plant-based meat alternatives for the rapidly growing plant-based market segment.

NSE has also developed proprietary technologies for the extraction of healthy omega 3 and 6 oils, as well as a protein concentrate from hemp.

On Behalf of the Board of Directors

Mr. J. Craig Goodwin President, Director

SOURCE: Naturally Splendid Enterprises Ltd.

News Provided by ACCESSWIRE via QuoteMedia

This release acts as a correction for the release posted on 8/29/2022 at 10:30 PM EDT from Naturally Splendid Enterprises Ltd. announcing its second quarter results for 2022 due to an error in comments stated

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSXV:NSP)(OTC PINK:NSPDF) announces its unaudited financial results for the six months ended June 30, 2022. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards

Naturally Splendid CFO Mr. George Ragogna states, "We apologize for an error in the comments overview of our Financial results. The first sentence below referenced our Administrative expenses for the six months ending June 30, 2022, and for the comparative period. We regret any confusion and have corrected the first sentence in the statement below to reflect the net loss and comprehensive loss."

Naturally Splendid recorded a net loss and comprehensive loss of $1,714,438 for the six months ended June 30, 2022, compared to a net loss of $1,750,988 during the six months ended June 30, 2021. Gross profit margins decreased by 2.6% of sales in the six months ended June 30, 2021, compared to the six months ended June 30, 2021. The Company's sales decreased by approximately $312,000 from the comparative period. During the six-month period ending June 30, 2022, selling and distribution expenses decreased by approximately $16,500, largely due to facility costs.

Administrative expenses for the six months ended June 30, 2022, decreased in 2022 compared to 2021 by $87,500.The decrease was primarily due to management & consulting fees, bank charges and legal fees.

Naturally Splendid recorded sales of $157,314 during the six months ended June 30, 2022, compared to $470,039 for the six months ended June 30, 2021. During the six months ended June 30, 2022, the Company's sales decreased by approximately $313,000 from the comparative period. The Company had decreased sales in its private-label bars and bites business by approximately $85,000. Branded hemp products decreased by approximately $170,200 and its Natera Sport products decreased by approximately $73,000. Sales in new Plant-based products decreased by approximately $4,300.

The Cost of Sales during the six months ended June 30, 2022, was $136,186 compared to $394,812 in 2021. The Company's sales were from its new line of plant-based entrees, which maintain a higher gross margin. The Company continues to focus on its higher-margin products and new commercial opportunities with its plant-based entrees.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid maintains a relationship Plasm Pharmaceutical, a company that has been approved for conducting a phase 2 clinical trial approved by Health Canada for the treatment of COVID-19.

NSE has also developed proprietary technologies for the extraction of healthy omega 3 and 6 oils, as well as a protein concentrate from hemp. For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-570-0902 x 103

On Behalf of the Board of Directors

Mr. J. Craig Goodwin CEO, Director

Naturally Splendid Enterprises Ltd. (NSP - TSX Venture; NSPDF - OTCQB; 50N - Frankfurt) #108-19100 Airport Way Pitt Meadows, BC, V3Y 0E2 Office: (604) 570-0902 E-mail : info@naturallysplendid.com Website: www.naturallysplendid.com

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control including, Naturally Splendid's ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

SOURCE: Naturally Splendid Enterprises Ltd.

News Provided by ACCESSWIRE via QuoteMedia

Naturally Splendid Enterprises Ltd.("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP) (OTC PINK:NSPDF) announces its unaudited financial results for the six months ended June 30, 2022. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards

Naturally Splendid CFO Mr. George Ragogna stated, "We are continuing to implement our plan focused on our plant-based opportunities, most notably PlanteinTM Plant-Based Foods. With most Covid restrictions now removed, we have been able to meet clients face to face at several trade shows after a multi-year hiatus, to promote the launch of our PlanteinTM retail line while developing national distribution and sales relationships. Responses from the trade shows have been overwhelmingly positive, resulting in multiple new accounts as well as building the foundation for many new business opportunities. The plant-based market is maturing, and consumers are demanding higher quality products, most notably beginning with taste. Feedback from these recent tradeshows has confirmed we have amongst the best tasting plant-based products available in the Canadian market, and demand for our PlanteinTM line continues to gain traction."

Strategic Focus on Manufacturing Plantein Plant-Based Foods

After careful consideration and discussions, the Naturally Splendid Enterprises management team, with support from the Board of Directors, has made a number of strategic decisions with the objective to prioritize the exclusive Canadian manufacturing and distribution opportunity of PlanteinTM Plant-Based Foods with Flexitarian Foods Pty. Ltd.

Since Naturally Splendid has partnered with Flexitarian Foods in an exclusive 10-year year manufacturing and distribution agreement for PlanteinTM for the Canadian market. The Company has also negotiated exclusive rights to the Plantein trademark for the same period. These exclusive agreements also have a 10-year renewal clause.

Outlook of the Plant-Based Market Opportunity

Today the retail market for plant-based foods is worth USD $10.9 billion with an expected Compound Annual Growth Rate (CAGR) of 12.2% (2022-2032). Furthermore, The National Research of Canada estimates that the protein demand will double to 943.5 million metric tons in 2054, and the opportunity for plant-based food is significant.

There are several reasons for the growing popularity of plant-based foods. The environmental sustainability of plant-based foods is a key factor as animal agriculture is a major contributor to greenhouse gas emissions, water consumption and deforestation. The UN reports that drought frequency and duration have increased by nearly a third globally since 2000. Plant-based foods require far less land and water than animal agriculture, generating fewer emissions.

Health concerns are another major factor driving the growth of the plant-based sector. Consumers are increasingly aware of the link between a plant-based diet and the reduction of chronic diseases such as heart disease, diabetes, and cancer.

Animal farming is also a key consideration for many people, as the factory farming of animals has come under increased scrutiny in recent years. Factory farming accounts for 37% of methane (CH4) emissions, which has more than 20 times the global warming potential of CO2. Plant-based agriculture uses an estimated 10% of the water required for animal farming and is far less damaging to the environment, driving even more environmentally concerned consumers to pursue a plant-based diet.

As the market for plant-based foods continues to grow, there is a tremendous opportunity for companies to provide products that meet consumer demand. Those that can supply healthy, sustainable, and delicious plant-based foods will be well-positioned to succeed in the coming years. Strategic Decisions Existing Operations

While focusing our resources on the PlanteinTM opportunity, all divisions, products and projects were reviewed thoroughly. The decisions on moving forward range from altering existing programs to suspending or eliminating certain projects and/or activities.

Bar manufacturing business including Elevate MeTM, NATERA, Woods WildTM, and contract manufacturing, are suspended while the facility undergoes expansion for the manufacturing of PlanteinTM plant-based products. Further plans are being developed and may include liquidating bars and bites assets or pursuing joint ventures or other business arrangements to manufacture and distribute bars and bites.

Prosnack Natural Foods will only focus on manufacturing PlanteinTM plant-based products under the Plantein brand, as well as for Private Label and Contract Manufacturing clients.

The Company has identified three (3) separate yet complimentary revenue streams generated from plant-based manufacturing:

PlanteinTM Brand - the Company will seek to list PlanteinTM branded products in both retail and foodservice outlets.

Private Label - the Company has access to over thirty (30) plant-based entrees created by Flexitarian Foods that will create significant private label opportunities.

Contract Manufacturing - In certain circumstances, Prosnack will manufacture for strategically selected contract manufacturing clients, producing their plant-based products in our facility.

The majority of the manufacturing equipment has been ordered, and various equipment has already arrived at our Pitt Meadows facility. We are experiencing delays in receiving certain manufacturing equipment due to supply challenges and ongoing logistics from Covid. During this time, the Company will continue to receive our plant-based inventories from Flexitarian Foods while we continue to work on completing our manufacturing lines at our own facility.

The Company will continue to progress with its Safe Quality Food (SQF) certification program, which will be completed upon the final commissioning of the new manufacturing lines. Although the facility was previously certified SQF2, the new plant-based production lines require an updated SQF plan to be developed and implemented.

We have also already sourced many of the ingredients required for manufacturing from Canadian suppliers. These ingredients have been evaluated with the oversight of Flexitarian Foods to confirm we are producing a product that replicates the flavour and texture profiles of the original recipes.

Sourcing ingredients locally is not only environmentally more sustainable but there are also significant savings associated with securing Canadian suppliers that directly contribute to bottom-line figures. The Company will see an almost immediate return by way of reducing production costs and improved inventory control, resulting in an anticipated increase in margins.

Naturally Splendid will no longer defend the NATERA brand name since we have secured the PlanteinTM trademark for Canada for our main priority, plant-based entrees. The Company is permitted to use the NATERA brand for certain bars and bites but will no longer seek the registered trademark.

Plasm Pharmaceutical Naturally Splendid has reached an agreement with Biologic to terminate the contract with Plasm Pharmaceutical and are negotiating a compensation package for all work done thus far for pursuing a potential treatment for Covid with the target drug Cavaltinib.

CHII Naturally Pure Hemp Operations remain as is focusing on online sales and bulk exports of hemp.

Pawsitive FX For the time being operations remain as is focusing on online sales of pet topicals. A further review will look to potentially sell this brand or consider other partnership-type scenarios.

Naturally Splendid recorded a net loss and comprehensive loss of $1,316,236 for the six months ended June 30, 2022, compared to a net loss of $1,403,685 during the six months ended June 30, 2021. Gross profit margins decreased by 2.6% of sales in the six months ended June 30, 2021, compared to the six months ended June 30, 2021. The Company's sales decreased by approximately $312,000 from the comparative period. During the six-month period ending June 30, 2022, selling and distribution expenses decreased by approximately $16,500, largely due to facility costs.

Administrative expenses for the six months ended June 30, 2022, decreased in 2022 compared to 2021 by $87,500. The decrease was primarily due to management & consulting fees, bank charges and legal fees.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid maintains a relationship Plasm Pharmaceutical, a company that has been approved for conducting a phase 2 clinical trial approved by Health Canada for the treatment of COVID-19.

On Behalf of the Board of Directors

Mr. J. Craig Goodwin CEO, Director

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control including, Naturally Splendid's ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

SOURCE: Naturally Splendid Enterprises Ltd.

News Provided by ACCESSWIRE via QuoteMedia

Naturally Splendid Enterprises Ltd. ("Naturally Splendid" or "NSE" or the "Company") (FRANKFURT:50N) (TSXV:NSP) (OTC PINK:NSPDF) announces that it intends to consolidate its issued and outstanding common shares at a ratio of up to fifteen (15) pre-consolidation shares to one (1) post-consolidation share (the "Consolidation"). The purpose of the Consolidation is to facilitate the Company's ability to attract future financings, generate greater investor interest, and improve trading liquidity

The Company currently has 330,624,458 common shares issued and outstanding. In the event the Company proceeds with the Consolidation, as opposed to a lesser ratio, the Company anticipates there would be 22,041,631 common shares issued and outstanding.

The Consolidation is subject to acceptance from the TSX-V and approval of the shareholders. The Company has scheduled the holding of an Annual General and Special Meeting for August 30, 2022.

The Company will not change its name in conjunction with the Consolidation.

About Naturally Splendid Enterprises Ltd.

Naturally Splendid is a plant-based food manufacturing and technology company that produces and distributes nutritious and delicious plant-based commodity products. Founded in 2010, the Company operates a Safe Quality Food Level 2 certified food manufacturing facility located just outside Vancouver, BC in Canada, focusing on producing an extensive range of plant-based entrees. Naturally Splendid has an exclusive 10-year manufacturing and distribution agreement for Canada with a division of Australia's largest plant-based food manufacturer, Flexitarian Foods Pty. Ltd.

In addition to producing the Company's own branded products, Naturally Splendid provides contract manufacturing services and private labeling for a variety of nutritional plant-based food products destined for multiple distribution channels. The Company has established healthy, functional foods under brands such as Natera Sport™, Natera Hemp Foods™, CHII™, Elevate Me™ and Woods Wild Bar™. The Company launched Natera Plant Based Foods, a line of delicious plant-based meat alternatives for the rapidly growing plant-based market segment.

Naturally Splendid maintains a relationship Plasm Pharmaceutical, a company that has been approved for conducting a phase 2 clinical trial approved by Health Canada for the treatment of COVID-19.

NSE has also developed proprietary technologies for the extraction of healthy omega 3 and 6 oils, as well as a protein concentrate from hemp.

On Behalf of the Board of Directors

Mr. J. Craig Goodwin CEO, Director

Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control including, Naturally Splendid's ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; customers will complete on sales contracts; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

SOURCE: Naturally Splendid Enterprises Ltd.

News Provided by ACCESSWIRE via QuoteMedia

Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSXV:NSP)(OTC PINK:NSPDF) announces its unaudited financial results for the three months ended March 31, 2022. All amounts are in Canadian dollars and are prepared in accordance with International Financial Reporting Standards

During this reporting period, Covid-19 uncertainty negatively affected sales of existing product lines as well as impaired launches of new product lines. On March 11, 2020, the World Health Organization declared the outbreak of the novel coronavirus ("COVID-19") a global pandemic resulting in governments worldwide, including the Canadian government, enacting extensive measures in an effort to limit the spread of the virus. These measures, which include social distancing, travel restrictions, outright travel bans, and closures of non-essential businesses including restaurants, created a challenging period for the Company.

Naturally Splendid CFO Mr. George Ragogna stated "We are continuing to implement our strategic plan focused on plant-based opportunities. The Company is evolving the manufacturing capabilities and capacities of our existing certified food manufacturing facility as our product mix shifts to more plant-based entrees and appetizers from bars and bites. We have shifted our product mix due in large part to the ten (10) year Canadian exclusive manufacturing and distribution agreement that we executed with Australia's largest plant-based manufacturer, Flexitarian Foods. This agreement is renewable for a further ten (10) years. Naturally Splendid has also secured licensing rights from Flexitarian Foods for the exclusive use of the PlanteinTM trademark in Canada. With the PlanteinTM trademark now secured, we have completed all retail packaging and websites to support this brand. The Company has attended several trade shows recently to promote the launch of the PlanteinTM retail line and national distribution relationships have been formed with Canada's two largest distributors, Sysco Canada and Gordon Food Services (GFS)."

Mr. Ragogna adds, "The Company has completed the design and begun the re-purposing of our existing certified food manufacturing facility in Pitt Meadows, BC. All manufacturing equipment required to produce our plant-based entrees has been ordered with many significant components of the manufacturing line having already arrived at the Pitt Meadows facility. However, there have been delays in receiving some components required to complete the full build-out of the new production lines due to ongoing logistics challenges that much of the manufacturing industry continues to experience. We will continue to receive our plant-based inventories from Flexitarian Foods while the manufacturing lines are still being set up in our own facility. Once the new manufacturing lines in our facility are commissioned, the Company will see an almost immediate return by way of reducing product costs, and improved inventory control, resulting in an anticipated increase in margins. We look forward to providing updates in a timely manner." Naturally Splendid recorded a net loss and comprehensive loss of $747,787 for the three months ended March 31, 2022, compared to a net loss of $767,478 during the three months ended March 31, 2021. Gross profit margins increased by 29% of sales in the three months ended March 31, 2021, compared to the three months ended March 31, 2021, this is due to the increased profit margins in the new plant-based sales. The Company's sales decreased by approximately $160,000 from the comparative period. During the three-month period ended March 31, 2022, selling and distribution expenses decreased by approximately $35,000 largely due to a decrease in production (facility costs, quality assurance and lab testing).

Administrative expenses increased in 2022 compared to 2021 by $22,000. The increase was primarily due to an increase in office, rent and salaries and management and consulting and decreases were primarily due to bank charges and interest. Office rent and salaries reflect the cost of the production, warehouse, office and outside freezer storage premises, and corporate salaries, the increase was due to some employee severances and an increase in freezer storage, otherwise, the office, rent and salaries remained consistent. Management and consulting fees increased due to new consultants for the new plant-based product line.

Naturally Splendid recorded sales of $93,453 during the three months ended March 31, 2022, compared to $144,143 for the three months ended March 31, 2021. The Company's sales decreased by approximately $50,690 from the comparative period. During the three months ended March 31, 2022, the Company's sales decreased by approximately $160,000 from the comparative period. The Company had decreased sales in its private-label bars and bites business by approximately $71,000. Branded hemp products decreased by approximately $2,500 and its Natera Sport products decreased by approximately $101,000. The Company had sales of approximately $50,000 in its new Plant-based products. This is in line with the Company shifting its focus on the new plant-based entrees for contract manufacturing, private label and branded products and will continue to sell to the international Korean markets.

The cost of Sales during the three months ended March 31, 2022, was $54,463 compared to $221,587 in 2021. The Company's gross margin percentage is 41.7% of sales, during the three months ended March 3, 2022.

The Company continues to focus on its higher-margin products and new commercial opportunities for its new plant-based products. The bulk hemp seeds sold at a lower gross margin percentage than compared to plant-based products and private label sales. The Company is now focused. Gross profits for the three months ended March 31, 2022, were $38,990 (42% of sales) compared to $31,791 (13% of sales) for the three months ended March 31, 2021.

About Naturally Splendid Enterprises Ltd.

Founded in 2010, NSE operates a food manufacturing facility just outside Vancouver, BC in Canada. The Company has established numerous healthy, functional foods under recognized brands such as Natera Sport™, Natera Hemp Foods, CHII, Elevate Me™ and Woods Wild Bar™, and most recently Natera Plant Based Foods, a line of delicious plant-based meat alternatives for the rapidly growing plant-based market segment. The Company has a myriad of new products and line extensions under development that are approaching launch. NSE, through its joint venture Plasm Pharmaceutical, has been approved for conducting a phase 2 clinical trial approved by Health Canada for treatment of COVID-19. NSE has also developed proprietary technologies for the extraction of high-demand, healthy omega 3 and 6 oils from hemp.

NSE contract manufacturers for healthy, functional food products and ingredients focusing on plant-based ingredients. The Company provides contract manufacturing services for many healthy food companies, private labeling a wide variety of nutritional food products destined for global healthy food markets.

For more information e-mail info@naturallysplendid.com or call Investor Relations at 604-5700902 (ext. 101)

On Behalf of the Board of Directors

Mr. J. Craig Goodwin CEO, Director

Naturally Splendid Enterprises Ltd. (NSP - TSX Venture; NSPDF - OTCQB; 50N - Frankfurt) #108-19100 Airport Way Pitt Meadows, BC, V3Y 0E2 Office: (604) 570-0902 Fax: (604) 465-1128 E-mail : info@naturallysplendid.com Website: www.naturallysplendid.com

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control including, Naturally Splendid's ability to compete with large food and beverage companies; sales of any potential products developed will be profitable; sales of shelled hemp seed will continue at existing rates or increase; the ability to complete the sales of all bulk hemp seed purchase orders; and the risk that any of the potential applications may not receive all required regulatory or legal approval. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.

SOURCE: Naturally Splendid Enterprises Ltd.

News Provided by ACCESSWIRE via QuoteMedia

Oculus VisionTech Inc. (TSXV: OVT) (OTCQB: OVTZ) (FSE: USF1) is pleased to announce the results of its 2022 Annual General Meeting ("AGM"). The AGM was held on September 15, 2022 in Vancouver, British Columbia. All resolutions put forward at the meeting were approved by shareholders. A total of 60,059,026 common shares (65.69% of the 91,422,569 issued and outstanding shares of the Company entitled to vote as of the July 19, 2022 record date for the AGM) were present in person or by proxy, constituted a quorum for the transaction of business and were voted at the AGM. The agenda items submitted at the AGM were passed as described below. Percentages indicated below reflect the percentage of the total number of shares voted at the AGM with respect to that agenda item.

The detailed results of voting by ballot in respect of the election of directors were as follows:

There were 6,890,471 broker non-votes with respect to the election of directors. Votes that were withheld and broker non-votes were counted for the purposes of determining the presence or absence of a quorum but had not other effect on the election of directors.

To ratify the appointment of Davidson & Company LLP, Chartered Professional Accountants, as the Company's independent public accounting firm for the fiscal year ending December 31, 2022. The votes cast for or against this agenda item, and the numbers of abstentions, were as follows:

There were no broker non-votes with respect to this agenda item. Abstentions were counted for purposes of determining the presence or absence of a quorum, and abstentions were deemed to be "votes cast" and had the same effect as a vote against this agenda item.

To approve the adoption of the Company's Omnibus Equity Incentive Compensation Plan. The votes cast for or against this agenda item, and the number of abstentions, were as follows:

There were 6,890,471 broker non-votes with respect to this agenda item. Broker non-votes and abstentions were counted for purposes of determining the presence or absence of a quorum. Abstentions were deemed to be "votes cast" and had the same effect as a vote against this agenda item. Broker non-votes were not deemed to be "votes cast", and therefore had no effect on the vote with respect to this proposal.

To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. The votes cast for or against this agenda item, and the number of abstentions, were as follows:

The detailed "Report of Voting Results" on all resolutions for the Company's AGM is available under the Company's profile on SEDAR, on the Company's website, in the Company's Current Report on Form 8-K as filed with the United States Securities and Exchange Commission available under the Company's profile on EDGAR or upon request by contacting the Company's Corporate Secretary at (604) 685-1017.

Oculus VisionTech Inc. (OVT), www.ovtz.com, is a cloud-native development-stage technology company focused on data compliance and digital privacy solutions for business customers worldwide. With offices in San Diego, California and Vancouver, British Columbia, the Company is currently expanding its' new ComplyTrust®www.complytrust.com, product suite which includes the ComplyScan® cloud data protection and compliance tool and Forget-Me-Yes® B2B data privacy Software-as-a-Service (SaaS) platform, optimizing CCPA, GDPR, LGPD and other regulatory compliance legislation for Salesforce organizations worldwide that provide businesses with secure data privacy tools enabling sustained and continuous global regulatory compliance of data subject rights. OVTZ's legacy Cloud-DPS digital content protection solution implements invisible forensic watermarking technology that seamlessly embeds imperceptible tracking components into documents and video-frame content that enables tamper-proof legal auditability for intellectual property protection.

Learn more about Oculus at www.ovtz.com or follow us on Twitter (https://twitter.com/OculusVT) or Facebook (https://www.facebook.com/OculusVisionTech/)

ComplyTrust Inc. https://complytrust.com/, a 100% wholly-owned subsidiary of Oculus VisionTech, is specifically focused on providing enterprise organizations and individuals with secure data privacy tools that provide sustained and continuous global regulatory compliance of data subject rights. Headquartered in San Diego, California, ComplyTrust was founded by industry veteran storage technology experts and is operated by an experienced management team.

Learn more about ComplyTrust at https://complytrust.com/.

Anton Drescher Telephone: (604) 685-1017 Fax: (604) 685-5777

Website: http://ovtz.com/ TSXV: https://money.tmx.com/en/quote/OVT/company#profile-section-company-spoke US OTC Markets (OTCQB): https://www.otcmarkets.com/stock/OVTZ/security Berlin Borse: https://www.boerse-berlin.com/index.php/Shares?isin=US67575Y1091 Frankfurt Borse: https://www.boerse-frankfurt.de/equity/oculus-visiontech

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements and information within the meaning of applicable securities laws (collectively, "forward-looking statements"), including the United States Private Securities Litigation Reform Act of 1995. All statements in this news release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among others, statements as to the intended uses of the proceeds received from the Offering. Often, but not always, forward-looking statements can be identified by words such as "pro forma", "plans", "expects", "may", "should", "budget", "schedules", "estimates", "forecasts", "intends", "anticipates", "believes", "potential" or variations of such words including negative variations thereof and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved. Actual results could differ from those projected in any forward-looking statements due to numerous factors including risks and uncertainties relating to, among others, the change of business focus of the management of Oculus, the inability of Oculus to pursue its current business objectives, the ability of the Company to obtain any required governmental, regulatory or stock exchange approvals, permits, consents or authorizations required, including TSXV final acceptance of the Offering and any planned future activities, and obtain the financing required to carry out its planned future activities. Other factors such as general economic, market or business conditions or changes in laws, regulations and policies affecting the Company's industry, may also adversely affect the future results or performance of the Company. These forward-looking statements are made as of the date of this news release and Oculus assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in these forward-looking statements. Although Oculus believes that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance those beliefs, plans, expectations, or intentions will prove to be accurate.

Investors should consider all of the information set forth herein and should also refer to the risk factors disclosed in Oculus' periodic reports filed from time-to-time with the United States Securities Exchange Commission and Canadian securities regulators. These reports and Oculus' public filings are available at www.sec.gov in the United States and www.sedar.com in Canada.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/137336

News Provided by Newsfile via QuoteMedia

Applied UV, Inc. (NasdaqCM: AUVI ) ("Applied UV" or the "Company"), a pathogen elimination technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically affirms that its pathogen killing technology SteriLumen's Airocide® and Lumicide are highly effective, differentiating solutions for addressing recent recommendations from the Centers for Disease Control (CDC) for cleaning and disinfecting settings that may be contaminated with Monkeypox and other orthopoxviruses.

In a recent publication, available here , the CDC provided considerations for disinfecting settings that may be contaminated with Monkeypox virus and highlighted the virus' sensitive to UV light, disinfectants and household cleaners in a tweet available here .

John F. Andrews Applied UV's CEO and Director stated, "As the only public, pure-play air and surface disinfection company, we are uniquely capable of capturing a significant portion of the emerging market opportunity affirmed by the CDC's recommendations. We have a growing list of business case uses for global, highly recognized customers such as Whole Foods, Del Monte, the Boston Red Sox, Opus One and Tru Infusion, across a diversity of vertical markets including healthcare, cannabis, correctional facilities, schools, wineries, dairy and food preservation that use our Airocide product suite and attest to its efficacy. The emergence of Monkeypox, which is an airborne and surface transmitted pathogen, presents an additional opportunity for us to apply our clinically-proven Airocide and Lumicide technologies to eradicate the virus from virtually any contaminated setting and reduce the risk of spread. Independent research has affirmed that orthopoxviruses, including Monkeypox, can survive in an environment for weeks or months and porous materials may harbor live viruses for longer periods of time. Airocide, which was developed for NASA and the University of Wisconsin at Madison, is more effective than ultra-violet (UV) solutions as it utilizes Photocatalytic Oxidation (PCO) technology to completely trap and destroy any and all carbon-based airborne viruses by oxidation without any harmful by-products, and our patented Lumicide surface and drain UVC technology will destroy any surface related Monkeypox virus. We are encouraged by the CDC's proactive efforts to provide guidance on ways to clean, disinfect and reduce the risk of spread, and we look forward to applying our industry-leading solution to help keep people healthy and safe."

The Airocide® System, originally developed for NASA with assistance from the University of Wisconsin at Madison, is an airborne pathogen killing technology that uses a patented combination of UVC and a proprietary, titanium dioxide based photocatalyst. Listed as an FDA Class II Medical device, the Airocide® technology is clinically proven and field tested to kill/remove/eliminate airborne pathogenic and non-pathogenic microorganisms, allergens, odors and harmful VOCs in a variety of applications and industries including healthcare, hospitality, grocery chains, wineries, commercial real estate, schools, dental offices and homes. Airocide® air purifiers are available at www.airocide.com .

Applied UV is focused on the development and acquisition of technology that address infection control in the healthcare, hospitality, commercial and municipal markets. The Company has two wholly owned subsidiaries - SteriLumen, Inc. ("SteriLumen") and Munn Works, LLC ("Munn Works"). SteriLumen's connected platform for Data Driven Disinfection™ applies the power of ultraviolet light (UVC) to destroy pathogens safely, thoroughly, and automatically, addressing the challenge of healthcare-acquired infections ("HAIs"). Targeted for use in facilities that have high customer turnover such as hospitals, hotels, commercial facilities, and other public spaces, the Company's Lumicide™ platform uses UVC LEDs in several patented designs for infection control in and around high-traffic areas, including sinks and restrooms, killing bacteria, viruses, and other pathogens residing on hard surfaces within devices' proximity. The Company's patented in-drain disinfection device, Lumicide Drain, is the only product on the market that addresses this critical pathogen intensive location. SteriLumen's Airocide® air purification devices are research backed, clinically proven and developed for NASA with assistance from the University of Wisconsin. Airocide® is listed as an FDA Class II Medical device, utilizes a proprietary photocatalytic (PCO) bioconversion technology that draws air into a reaction chamber that converts damaging molds, microorganisms, dangerous airborne pathogens, destructive VOCs, allergens, odors and biological gasses into harmless water vapor and green carbon dioxide without producing ozone or other harmful byproducts. Airocide® applications include healthcare, hospitality, grocery chains, wine making facilities, commercial real estate, schools, dental offices, post-harvest, grocery, cannabis facilities and homes. For more information about Applied UV, Inc., and its subsidiaries, please visit the following websites: https://www.applieduvinc.com/

The information contained herein may contain "forward‐looking statements." Forward‐looking statements reflect the current view about future events. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "future," "intend," "plan," or the negative of these terms and similar expressions, as they relate to us or our management, identify forward‐looking statements. Such statements include, but are not limited to, statements contained in this press release relating to the view of management of Applied UV concerning its business strategy, future operating results and liquidity and capital resources outlook. Forward‐looking statements are based on the Company's current expectations and assumptions regarding its business, the economy and other future conditions. Because forward–looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company's actual results may differ materially from those contemplated by the forward‐looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward‐looking statements. Factors or events that could cause the Company's actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. The Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward‐looking statements to conform these statements to actual results.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005294/en/

For additional Company Information: Applied UV Inc. John F. Andrews Applied UV CEO, Director john.andrews@applieduvinc.com

Contact: Brett Maas, Managing Principal Hayden IR brett@haydenir.com (646) 536-7331

News Provided by Business Wire via QuoteMedia

dynaCERT Inc. (TSX: DYA) (OTCQX: DYFSF) (FRA: DMJ) (" dynaCERT " or the "Company") is pleased to announce its participation exhibiting at the IAA Transportation Trade Show 2022 being held from September 20 th to 25 th in Hanover, Germany. IAA Transportation, under the motto "People and Goods on the Move", is the world's largest platform for transport and logistics and will host over 2,000 exhibitors from across the world. More than 250,000 attendees are expected during the six days of the show.

At the IAA Transportation Trade Show 2022 dynaCERT will be exhibiting its proprietary HydraGEN™ Technology designed to reduce fuel consumption and pollutants such as GHG's currently available globally for small, medium and large diesel vehicles and generators.

IAA Transportation presents the world of buses, van, trucks, trailers and bodies in all its facets. The exhibition provides content for all aspects of sustainable, social, technical, economic and political aspects of global transport. International opinion leaders from all relevant industries will be discussing the challenges of our time and present their solutions and visions for the global and regional transport of the future.

dynaCERT will be exhibiting at Booth D15 in Hall 24 with demonstrations of its flagship products, the internationally renowned HG1 and HG2.

Daily presentations of the company's HydraLytica TM app will held at 11:00 am and 3:00 pm throughout the exhibition.

Enrico Schlaepfer, Vice President Global Sales & Marketing for dynaCERT , states, "As part of our CCF (Corporate Carbon Footprint) at dynaCERT , we not only want to reduce world-wide CO 2 e emissions with our HydraGEN™ Technology, but also feel compelled this year to make our booth at the "IAA Transportation" absolutely 100% climate neutral. We pursue an approach that is more transparent and comprehensible than a simple CO 2 e-Offset Certificate. For each component of our exhibit, we calculate the exact amount of CO 2 e emissions and then offset this GHG footprint by planting trees at the Hanover exhibition center and the surrounding area. The Company's HydraGEN™ Technology is the one technology that bridges the gap to the ecological transition and provides a cost-effective solution to the world today!"

Jim Payne, President & CEO of dynaCERT , comments, "After the unexpected planetary disruptions of the past two years caused by the COVID pandemic, dynaCERT is extremely pleased and very eager to be able to relaunch its high-profile global marketing drives and trade show initiatives. With our 47 dealers world-wide supported by our dedicated European and North American in-house professionals, we are strongly committed to furthering our international presence in 2022 and beyond."

For further information on IAA Transportation 2022, please visit their website at: https://www.iaa-transportation.com/en

dyna CERT Inc. manufactures and distributes Carbon Emission Reduction Technology for use with internal combustion engines. As part of the growing global hydrogen economy, our patented technology creates hydrogen and oxygen on-demand through a unique electrolysis system and supplies these gases through the air intake to enhance combustion, resulting in lower carbon emissions and greater fuel efficiency. Our technology is designed for use with many types and sizes of diesel engines used in on-road vehicles, refrigerated trailers, off-road construction, power generation, mining and forestry equipment, marine vessels and railroad locomotives. Website: www.dynaCERT.com .

Except for statements of historical fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance of achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.

Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: uncertainty as to whether our strategies and business plans will yield the expected benefits; availability and cost of capital; the ability to identify and develop and achieve commercial success for new products and technologies; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; the uncertainty of the emerging hydrogen economy; including the hydrogen economy moving at a pace not anticipated; our ability to secure and maintain strategic relationships and distribution agreements; and the other risk factors disclosed under our profile on SEDAR at www.sedar.com . Readers are cautioned that this list of risk factors should not be construed as exhaustive.

The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.

Neither The Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of The Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of the release.

On Behalf of the Board Murray James Payne, CEO

View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005057/en/

Jim Payne, CEO & President dynaCERT Inc. #101 – 501 Alliance Avenue Toronto, Ontario M6N 2J1 +1 (416) 766-9691 x 2 jpayne@ dynaCERT .com

Investor Relations dynaCERT Inc. Nancy Massicotte +1 (416) 766-9691 x 1 nmassicotte@ dynaCERT .com

News Provided by Business Wire via QuoteMedia

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company") a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces that it has signed an agreement with Caris Life Sciences ® (Caris), a leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare.

"Our goal is to develop immunotherapies that are personalized for each patient, and Caris' extensive library of clinical data, cutting-edge biomarker technology, and expertise will be invaluable in achieving our objectives," stated Dr. Giuseppe Del Priore, BriaCell's Chief Medical Officer. "We expect Caris' unique platform to help us identify patients who do not respond to existing treatments and are more likely to benefit from our immunotherapy treatments."

Under the terms of the agreement, Caris will help BriaCell with efficient patient identification, accelerating enrollment for its current Phase I/II clinical trial in advanced metastatic breast cancer of certain genetically defined subgroups. The partnership between BriaCell and Caris leverages Caris' Right-In-Time (RIT) Clinical Trial Network, a group of over 495 oncology sites that are able to quickly identify and enroll eligible patients in biomarker-directed clinical trials. This service offers patients and physicians access to the most cutting-edge precision medicine in development. Additionally, through Caris' comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing), Caris will perform tumor profiling for the patients enrolled in the clinical trial.

BriaCell is an immuno-oncology-focused biotechnology company developing targeted and effective approaches for the management of cancer. More information is available at https://briacell.com/ .

Caris Life Sciences ® (Caris) is the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare and improve patient outcomes. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale clinico-genomic database and cognitive computing needed to analyze and unravel the molecular complexity of disease. This information provides an unmatched resource and the ideal path forward to conduct the basic, fundamental research to accelerate discovery for detection, diagnosis, monitoring, therapy selection and drug development to improve the human condition.

With a primary focus on cancer, Caris' suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physicians and researchers better detect, diagnose and treat patients. Caris' latest advancement is a blood-based, circulating nucleic acids sequencing (cNAS) assay that combines comprehensive molecular analysis (Whole Exome and Whole Transcriptome Sequencing from blood) and serial monitoring – making it the most powerful liquid biopsy assay ever developed.

Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Denver, Tokyo, Japan and Basel, Switzerland. Caris provides services throughout the U.S., Europe, Asia and other international markets. To learn more, please visit CarisLifeSciences.com or follow Caris on Twitter ( @CarisLS ).

This press release contains "forward-looking statements" that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim," "should," "will," "would," or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on BriaCell's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading "Risks and Uncertainties" in the Company's most recent Management's Discussion and Analysis, under the heading "Risk Factors" in the Company's most recent Annual Information Form, and under "Risks and Uncertainties" in the Company's other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available under the Company's profiles on SEDAR at www.sedar.com and on EDGAR at www.sec.gov . Forward-looking statements contained in this announcement are made as of this date, and BriaCell Therapeutics Corp. undertakes no duty to update such information except as required under applicable law.

Neither Toronto Stock Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this release.

Company Contact: William V. Williams, MD President & CEO 1-888-485-6340 info@briacell.com

Media Relations: Jules Abraham Director of Public Relations CORE IR 917-885-7378 julesa@coreir.com

Investor Relations Contact: CORE IR investors@briacell.com

Caris Life Sciences Media Contact: Lisa Burgner corpcomm@carisls.com 214-294-5606

News Provided by GlobeNewswire via QuoteMedia

New Bloom lab will support operations in the Honolulu area and surrounding region

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces the opening of a new location in in the Honolulu area.

The new location provides expanded laboratories for operational health services and diagnostic testing to meet continued demand. Bloom has also added a local team. The Honolulu location will serve film/TV productions in addition to new opportunities with local businesses and organizations in the surrounding area.

"Adding services in Honolulu shows flexibility in our business model," said Andrew Morton, CEO of Bloom. "We've shown the local market in the Hawaiian islands our willingness to bring services directly to them. The clients that brought us to Hawaii are a great baseline for Bloom to prove out a longer term model of support for health services across the United States. We continue to be focused on delivering technology enabled, operational health services to large employers."

The Company also announces that in connection with closing the second tranche of its previously announced non-brokered private placement offering (the "Offering") on July 18, 2022, total compensation paid was C$33,240 and 166,200 compensation options, and not as previously indicated. All securities issued in connection with the Offering are subject to a statutory hold period until November 19, 2022 in accordance with applicable securities laws.

About Bloom Health Partners Inc. Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) is a global platform for healthcare security, diagnostic testing and occupational health-tech. Our mission is to ensure that "unstoppable is possible" for businesses and their employees through innovative, customized healthcare models. Bloom offers a system for businesses and organizations that helps engage employees and creates strategies to manage health and safety. Our stable, scalable system is an integrated health-tech platform that securely manages data while delivering comprehensive workplace health and safety outcomes.

For more information: info@bloomhealthpartners.com

On behalf of the board of directors,

Andrew Morton, Chief Executive Officer

This news release includes forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in the Company's forward-looking statements include the potential that milestones may not be satisfied, acquisitions may not achieve expected benefits, financing requirements, and the other risk factors described in the Company's filings with Canadian securities regulators on www.sedar.com. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/137059

News Provided by Newsfile via QuoteMedia

GOAT Industries Ltd. (the " Company " or " GOAT ") (CSE: GOAT), is pleased to announce the Company has entered into a non-binding Letter of Intent (the " LOI ") dated September 14, 2022 with 1000288601 Ontario Inc. (" Ontario Co ").

The LOI contemplates a proposed transaction (the " Proposed Transaction "), whereby GOAT would acquire all issued and outstanding securities of Ontario Co by way of a share exchange agreement (the " Share Exchange "). Ontario Co is in the process of acquiring the Canadian license for a Direct Lithium Extraction technology (the " DLE Technology ") developed by private industry, as well as University researchers based out of Australia.

It is the Company's understanding that the DLE Technology is more cost-effective extraction technology than fractional crystallization, membrane filtering, MOF's, adsorption, reverse osmosis, and ion exchange.

The DLE Technology has the potential to reduce capital and operating costs, while accelerating battery metal project startups via:

The proposed transaction is expected to be completed pursuant to available prospectus exemptions in accordance with applicable securities legislation. GOAT and Ontario Co have agreed to negotiate in good faith the terms of a definitive written agreement with respect to the proposed transaction within 60 days from the LOI. The proposed transaction is subject to receipt of all necessary regulatory approvals, including, as applicable, approval of the Canadian Securities Exchange (CSE), completion of due diligence reasonable or customary in a transaction of a similar nature and entering into a definitive agreement, among other conditions. The proposed transaction would be an arm's-length transaction for GOAT and would not constitute a fundamental change or result in a change of control of the company, within the meaning of the policies of the CSE.

GOAT Industries is an investment issuer focused on investing in high-potential companies operating across a variety of sectors. The paramount goal of the Company will be to generate maximum returns from its investments.

The Company's final prospectus, financial statements and management's discussion and analysis, among other documents, are all available on its profile page on SEDAR at www.sedar.com .

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

CAUTIONARY STATEMENT REGARDING "FORWARD-LOOKING" INFORMATION

This news release contains certain forward-looking statements within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. The Company has provided the forward-looking statements in reliance on assumptions that it believes are reasonable at this time. All such forward-looking statements involve substantial known and unknown risks and uncertainties (including those risk factors identified in the Company's prospectus dated February 15, 2022), certain of which are beyond the Company's control. Such risks and uncertainties include, without limitation, delays resulting from or inability to obtain required regulatory approval. The reader is cautioned that the assumptions used in the preparation of the forward-looking statements may prove to be incorrect and the actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements. Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what benefits, including the amount of proceeds, the Company will derive therefrom. Readers are cautioned that the foregoing list of factors is not exhaustive. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

GOAT Industries Ltd. Investor Relations Email: alex@goatindustries.co Phone: 604-687-2038

News Provided by GlobeNewswire via QuoteMedia

Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.

Enabling Businesses To Trade With Confidence

Continuously Develop New Products

Good Quality, Lowest Price, Best Service

Naturally Splendid Plantein Adds Greenbridge Distributor Network

Featured Products

News & Blog

Follicle Revival Reviews – Read This Ingredients Report NOW Before Buying!

Close banner

Close banner

Animal models of Parkinson's disease and their applications | JPRLS

[Sale] More Effective Viagra Levitra - Fort Carson Mountaineer

YouTube

Food Partying! with iChina and Wild Onion | The Food Party! | Laura Stec | Palo Alto Online |

Exipure Reviews (Real or Fake) Bogus Ingredients List With Side Effects Risk? - MarylandReporter.com

Never Take This Before Bedtime, Warn Pharmacists — Eat This Not That

bel-logo.svg